These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 10945849

  • 1. Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats.
    Martin TJ, Kim SA, Cannon DG, Sizemore GM, Bian D, Porreca F, Smith JE.
    J Pharmacol Exp Ther; 2000 Sep; 294(3):975-82. PubMed ID: 10945849
    [Abstract] [Full Text] [Related]

  • 2. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
    Mattia A, Farmer SC, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Bowen WD, Porreca F.
    J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
    [Abstract] [Full Text] [Related]

  • 3. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 4. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [Abstract] [Full Text] [Related]

  • 5. Alkylation of opioid receptors by 5'-naltrindole-isothiocyanate injected into the nucleus accumbens of rats: receptor selectivity and anatomical diffusion.
    Martin TJ, McIntosh S, Smith JE.
    Synapse; 2006 Oct; 60(5):384-91. PubMed ID: 16847946
    [Abstract] [Full Text] [Related]

  • 6. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 Oct; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

  • 7. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
    Hammond DL, Stewart PE, Littell L.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
    [Abstract] [Full Text] [Related]

  • 8. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN, Walker EA.
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [Abstract] [Full Text] [Related]

  • 9. Differential involvement of mu-opioid receptors in the rostral versus caudal nucleus accumbens in the reinforcing effects of heroin in rats: evidence from focal injections of beta-funaltrexamine.
    Martin TJ, Kim SA, Lyupina Y, Smith JE.
    Psychopharmacology (Berl); 2002 May; 161(2):152-9. PubMed ID: 11981595
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW, Bernstein RN, Yamamura HI, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [Abstract] [Full Text] [Related]

  • 11. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.
    Martin TJ, Dworkin SI, Smith JE.
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1135-40. PubMed ID: 7891326
    [Abstract] [Full Text] [Related]

  • 12. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
    Bilsky EJ, Qian X, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
    [Abstract] [Full Text] [Related]

  • 13. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE, Hammond DL.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
    [Abstract] [Full Text] [Related]

  • 14. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K, Rónai AZ.
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
    [Abstract] [Full Text] [Related]

  • 15. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H, Spaulding A, Leitermann R, Wu HE, Nagase H, Tseng LF.
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [Abstract] [Full Text] [Related]

  • 16. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
    Fraser GL, Pradhan AA, Clarke PB, Wahlestedt C.
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
    [Abstract] [Full Text] [Related]

  • 17. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.
    Stevenson GW, Folk JE, Rice KC, Negus SS.
    J Pharmacol Exp Ther; 2005 Jul; 314(1):221-31. PubMed ID: 15792997
    [Abstract] [Full Text] [Related]

  • 18. Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone.
    Rowlett JK, Wilcox KM, Woolverton WL.
    J Pharmacol Exp Ther; 1998 Jul; 286(1):61-9. PubMed ID: 9655842
    [Abstract] [Full Text] [Related]

  • 19. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K, Varga EV, Alfaro-Lopez J, Tang X, Vanderah TW, Porreca F, Hruby VJ, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 2003 Feb; 304(2):683-8. PubMed ID: 12538822
    [Abstract] [Full Text] [Related]

  • 20. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
    Porreca F, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):147-52. PubMed ID: 1328602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.